AAAAAA
Results:
1-12
|
Results: 12
Authors:
McKeage, MJ
Citation: Mj. Mckeage, Lobaplatin: a new antitumour platinum drug, EXPERT OP I, 10(1), 2001, pp. 119-128
Authors:
Holmes, RJ
McKeage, MJ
Murray, V
Denny, WA
McFadyen, WD
Citation: Rj. Holmes et al., cis-dichloroplatinum(II) complexes tethered to 9-aminoacridine-4-arboxamides: synthesis and action in resistant cell lines in vitro, J INORG BIO, 85(2-3), 2001, pp. 209-217
Authors:
McKeage, MJ
Hsu, T
Screnci, D
Haddad, G
Baguley, BC
Citation: Mj. Mckeage et al., Nucleolar damage correlates with neurotoxicity induced by different platinum drugs, BR J CANC, 85(8), 2001, pp. 1219-1225
Authors:
Hambley, TW
Ling, ECH
O'Mara, S
McKeage, MJ
Russell, PJ
Citation: Tw. Hambley et al., Increased targeting of adenine-rich sequences by (2-amino-2-methyl 3-butanone oxime)dichloroplatinum(II) and investigations into its low cytotoxicity, J BIOL I CH, 5(6), 2000, pp. 675-681
Authors:
McKeage, MJ
Berners-Price, SJ
Galettis, P
Bowen, RJ
Brouwer, W
Ding, L
Zhuang, L
Baguley, BC
Citation: Mj. Mckeage et al., Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes, CANC CHEMOT, 46(5), 2000, pp. 343-350
Authors:
Screnci, D
McKeage, MJ
Galettis, P
Hambley, TW
Palmer, BD
Baguley, BC
Citation: D. Screnci et al., Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs, BR J CANC, 82(4), 2000, pp. 966-972
Authors:
McKeage, MJ
Citation: Mj. Mckeage, Clinical toxicology of platinum-based cancer chemotherapeutic agents, CANC DRUG, 7, 2000, pp. 251-275
Authors:
McKeage, MJ
Haddad, GG
Ding, L
Galettis, P
Screnci, D
Zhuang, L
Baguley, BC
Citation: Mj. Mckeage et al., Neuroprotective interactions in rats between paclitaxel and cisplatin, ONCOL RES, 11(6), 1999, pp. 287-293
Authors:
Links, M
Watson, S
Lethlean, K
Aherne, W
Kirsten, F
Clarke, S
Law, M
Friedlander, M
Galettis, P
McKeage, MJ
Citation: M. Links et al., Vinblastine pharmacokinetics in patients with non-small cell lung cancer given cisplatin, CANCER INV, 17(7), 1999, pp. 479-485
Authors:
Galettis, P
Carr, JL
Paxton, JW
McKeage, MJ
Citation: P. Galettis et al., Quantitative determination of platinum complexes in human plasma generatedfrom the oral antitumour drug JM216 using directly coupled high-performance liquid chromatography-inductively coupled plasma mass spectrometry without desolvation, J ANAL ATOM, 14(6), 1999, pp. 953-956
Authors:
Le Chevalier, T
Berille, J
Zalcberg, JR
Millward, MJ
Monnier, A
Douillard, JY
McKeage, MJ
James, R
Soulas, F
Loret, C
Bougon, N
Bizzari, JP
Citation: T. Le Chevalier et al., Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer, SEMIN ONCOL, 26(3), 1999, pp. 13-18
Authors:
Berners-Price, SJ
Bowen, RJ
Galettis, P
Healy, PC
McKeage, MJ
Citation: Sj. Berners-price et al., Structural and solution chemistry of gold(I) and silver(I) complexes of bidentate pyridyl phosphines: selective antitumour agents, COORD CH RE, 186, 1999, pp. 823-836
Risultati:
1-12
|